Ortega-Ayala, A.; RodrÃguez-Rivera, N.S.; Andrés, F.d.; LLerena, A.; Pérez-Silva, E.; Espinosa-Sánchez, A.G.; Molina-Guarneros, J.A.
Pharmacogenetics of Metformin Transporters Suggests No Association with Therapeutic Inefficacy among Diabetes Type 2 Mexican Patients. Pharmaceuticals 2022, 15, 774.
https://doi.org/10.3390/ph15070774
AMA Style
Ortega-Ayala A, RodrÃguez-Rivera NS, Andrés Fd, LLerena A, Pérez-Silva E, Espinosa-Sánchez AG, Molina-Guarneros JA.
Pharmacogenetics of Metformin Transporters Suggests No Association with Therapeutic Inefficacy among Diabetes Type 2 Mexican Patients. Pharmaceuticals. 2022; 15(7):774.
https://doi.org/10.3390/ph15070774
Chicago/Turabian Style
Ortega-Ayala, Adiel, Nidia Samara RodrÃguez-Rivera, Fernando de Andrés, Adrián LLerena, Eliseo Pérez-Silva, Adriana Guadalupe Espinosa-Sánchez, and Juan Arcadio Molina-Guarneros.
2022. "Pharmacogenetics of Metformin Transporters Suggests No Association with Therapeutic Inefficacy among Diabetes Type 2 Mexican Patients" Pharmaceuticals 15, no. 7: 774.
https://doi.org/10.3390/ph15070774
APA Style
Ortega-Ayala, A., RodrÃguez-Rivera, N. S., Andrés, F. d., LLerena, A., Pérez-Silva, E., Espinosa-Sánchez, A. G., & Molina-Guarneros, J. A.
(2022). Pharmacogenetics of Metformin Transporters Suggests No Association with Therapeutic Inefficacy among Diabetes Type 2 Mexican Patients. Pharmaceuticals, 15(7), 774.
https://doi.org/10.3390/ph15070774
